TKG Oncology Voices - Translating insights into action TKG Oncology Voices - Translating insights into action
May 28

TKG and Oncology Executive Thought Leaders Discuss Technology and Process Innovations in Clinical Operations

The panel shared experiences and insights gained over the last 14 months on the current state of cancer center operations, environmental challenges facing cancer care delivery, organizational and financial challenges, and various innovations in clinical operations.

New York, NY (May 21, 2021) – The Kinetix Group (TKG) assembled Oncology Thought Leaders from leading cancer centers and advocacy organizations from across the nation to virtually discuss insights and innovations in cancer care delivery amidst accelerating disruptive forces, given the challenges of the current COVID-19 pandemic. Participants included senior executives from 14 leading organizations including Johns Hopkins Medicine, Duke Health System, University Hospitals Seidman Cancer Center, Northwestern University, City of Hope, Moffitt Cancer Center, Fox Chase Cancer Center, The James Cancer Center at Ohio State University, the Patient Advocate Foundation, University of Vermont, Rush Health, and Jefferson Health.

Topics discussed included Critical Issues Facing Cancer Care Delivery Models, Technology Driven Innovations in Clinical Operations, and People and Process Driven Innovations to High Quality Cancer Care. The panel shared experiences and insights gained over the last 14 months on the current state of cancer center operations, environmental challenges facing cancer care delivery, organizational and financial challenges, and various innovations in clinical operations. Many of these discussions incorporated advancements in technology as a significant driver of these changes.

Warren Smedley, VP of Oncology Consulting at The Kinetix Group and moderator said, “The last year and a half has accelerated the rate of innovation and change in cancer care delivery, which has highlighted both the strengths and weaknesses of our care delivery models. Cancer is a complicated disease to treat and 2020 made it even more evident that we need to creatively address the burdens of a cancer diagnosis for all who are impacted. This working group reinforces TKG’s commitment to aligning our customers’ shared goals and priorities with the recommendations, changes, and innovations that are needed to accelerate their competitive positions in a chaotic marketplace.”

TKG’s Oncology Thought Leaders Network brings leading oncology executives together to garner insights, share best practices, identify opportunities to generate real world evidence in pilot project settings, and activate these learnings to drive healthcare transformation. Insights and key learnings from the session are available by emailing oncology@thekinetixgroup.com.

About The Kinetix Group

The Kinetix Group (TKG) empowers life science companies to effectively engage with health system and payer customers by developing strategies and real-world solutions aimed at impacting the right patient, at the right time, with the right care. TKG also works directly with health systems and payers to build and implement value-based delivery models for identified patient populations. To learn more, go to https://TKGOncology.com/.

CONTACT:

Warren Smedley

oncology@thekinetixgroup.com

Leave a reply

Your email address will not be published.